News from pivotal therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 11, 2014, 10:34 ET

Pivotal Therapeutics engages Kilmer Lucas for cross-border investor relations

WOODBRIDGE, ON, June 11, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

May 30, 2014, 16:38 ET

Pivotal Therapeutics Announces First Quarter Financial Results

WOODBRIDGE, ON, May 30, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CSE:PVO), ("Pivotal" or the "Company"), a specialty...

May 14, 2014, 19:28 ET

Pivotal Therapeutics announces changes to the Board of Directors

WOODBRIDGE, ON, May 14, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF)(CSE:PVO) ("Pivotal" or "the Company"), a specialty...

May 13, 2014, 13:51 ET

Pivotal Therapeutics Engages Brandkarma LLC.

WOODBRIDGE, ON, May 13, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on...

May 07, 2014, 11:39 ET

Pivotal Therapeutics announces issuance of U.S. Patent 8,715,648 for its unique 6:1 EPA:DHA formulation

WOODBRIDGE, ON, May 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a...

May 06, 2014, 13:50 ET

Pivotal Therapeutics presented two posters at American Heart Association's ATVB 2014 Scientific Sessions

WOODBRIDGE, ON, May 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a...

May 01, 2014, 15:47 ET

Pivotal Therapeutics to present at American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a...

May 01, 2014, 14:40 ET

Pivotal Therapeutics issues correction to 2013 financial results press release

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on...

Apr 30, 2014, 21:19 ET

Pivotal Therapeutics Announces 2013 Financial Results

WOODBRIDGE, ON, April 30, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus...

Apr 23, 2014, 17:37 ET

Pivotal Therapeutics announces resignation of directors

WOODBRIDGE, ON, April 23, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus...

Apr 08, 2014, 14:58 ET

Pivotal Therapeutics grants incentive stock options

WOODBRIDGE, ON, April 8, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a...

Mar 14, 2014, 17:40 ET

Pivotal Therapeutics grants incentive stock options

WOODBRIDGE, ON, March 14, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus...

Mar 10, 2014, 09:40 ET

Pivotal Therapeutics appoints pharmaceutical executive James Connolly to Board of Directors

WOODBRIDGE, ON, March 10, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus...

Mar 04, 2014, 13:00 ET

Pivotal Therapeutics cierra financiación

- Pivotal Therapeutics cierra financiación; recibe más de 7,7 millones de dólares canadienses para la comercialización de...

Mar 04, 2014, 08:00 ET

Pivotal Therapeutics closes financing; receives over CDN $7.7 million to further VASCAZEN® commercialization

WOODBRIDGE, ON, March 4, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus...

Jan 30, 2014, 04:37 ET

Pivotal Therapeutics anuncia una Notificación de Aprobación para su formulación 6:1 EPA:DHA

 - Pivotal Therapeutics anuncia una Notificación de Aprobación para la Patente de Estados Unidos en su...

Jan 29, 2014, 11:50 ET

Pivotal Therapeutics announces Notice of Allowance for U.S. Patent on its unique 6:1 EPA:DHA Formulation

WOODBRIDGE, ON, Jan. 29, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus...

Nov 29, 2013, 16:38 ET

Pivotal Therapeutics Announces Third Quarter 2013 Financial Results

WOODBRIDGE, ON, Nov. 29, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus...

Nov 01, 2013, 21:02 ET

Pivotal Therapeutics Inc. Announces Extension of Debt Financing

WOODBRIDGE, ON, Nov. 1, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus...

Oct 30, 2013, 17:45 ET

John P. Nicholson Jr., MD, MBA, FACC Appointed to Pivotal Board of Directors

WOODBRIDGE, ON, Oct. 30, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge